A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease

por Poupon-Bejuit, L., Hughes, M. P., Liu, W., Geard, A., Faour-Slika, N., Whaler, S., Massaro, G., Rahim, A. A.
Publicado 2022